ArticleAnalytical and bioanalytical chemistry2026
Development of a metabolomic LC-QTOF method for bioactive compound production control in plant cell cultures.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The search for sustainable and environmentally friendly production processes drives the development of innovative biotechnological solutions, such as the use of plant cell cultures in controlled bioreactors. These systems are a promising platform for producing high-value bioactive compounds for the pharmaceutical, cosmetic, and agricultural industries. A critical challenge of this technology is the understanding and efficient control of the metabolome to optimize the synthesis of target molecules. In this study, we developed an ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-QTOF) method for the comprehensive metabolomic profiling of extracts derived from in vitro cultures of plant cells (Ocimum basilicum). The analytical separation was achieved using reverse-phase chromatography with an optimized solvent gradient. Electrospray ionization (ESI) in both positive and negative modes was applied to maximize analytical coverage. A key feature of this methodology was the utilization of the Zeno trap technology (zenoTOF 7600), which significantly enhanced the sensitivity and improved the metabolite annotation confidence by generating high-quality MS/MS spectra. Data analysis was carried out using MS-DIAL software and subsequent methods to identify and classify the compounds and pinpoint those with significant changes or crucial roles in biosynthetic pathways. This metabolomic approach provides deeper insights into the biosynthesis of active molecules and establishes a robust control strategy for targeted compound production, contributing directly to the advancement of sustainable bioprocesses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.